Drug Safety Update
November 2023: E-cigarette use or vaping: reminder to remain vigilant for suspected adverse reactions and safety concerns and report them to the Yellow Card scheme
January 2021: SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery
November 2020: Bupropion (Zyban): risk of serotonin syndrome with use with other serotonergic drugs
January 2020: E-cigarette use or vaping: reporting suspected adverse reactions, including lung injury
October 2009: Smoking and smoking cessation: clinically significant interactions with commonly used medicines
November 2008: Varenicline: adverse psychiatric reactions, including depression
Smoking cessation interventions are a cost-effective way of reducing ill health and prolonging life. Smokers should be advised to stop and offered help if interested in doing so.
Where possible, smokers should have access to a smoking cessation clinic for behavioural support.
Local Guidance
MTW Smoking Cessation Treatments
